Thus, in the present study, we developed a prognostic gene signature for ESCC patients with VEGF overexpression via machine learning–based analysis of next‐generation sequencing (NGS) results, data from The Cancer Genome Atlas (TCGA), and clinical datasets. This evidence concerns the gene VEGFA and esophageal squamous cell carcinoma.